<DOC>
	<DOCNO>NCT00003878</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Giving drug different way may kill tumor cell . PURPOSE : Phase II trial study effectiveness implant carmustine wafer treat patient brain metastasis undergo surgery remove tumor .</brief_summary>
	<brief_title>Carmustine Implants Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : - Determine local recurrence rate patient supratentorial metastatic brain tumor undergoing surgical resection treat polifeprosan 20 carmustine implant ( Gliadel wafer ) . - Determine incidence time recurrence distant site within CNS patient treatment . - Determine median , 6-month , 1-year , 2-year survival patient regimen . - Determine incidence severity cognitive function loss patient regimen . - Determine incidence severity CNS systemic toxic effect patient regimen . OUTLINE : Patients receive 8 polifeprosan 20 carmustine implant ( Gliadel wafer ) implant resected tumor cavity . Patients follow day 7 day discharge , 1 month , 3 month , every 3 month 21 month , survival . PROJECTED ACCRUAL : A total 90 patient accrue study within 30 month .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Supratentorial brain metastasis surgery recommend Solitary , unilateral , intracranial mass consistent metastasis MRI scan OR Two brain lesion consistent metastasis MRI scan Lesions must accessible single craniotomy Metastatic lesion clearly distinct tumor bed benign lesion Intraoperative frozen section diagnosis metastatic tumor CNS lesion No prior malignant intracranial neoplasm No lesion ( ) brainstem No open communication resection cavity ventricle follow resection PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 60100 % Life expectancy At least 3 month Hematopoietic No concurrent hematologic disorder Hepatic No concurrent hepatic disease Renal No concurrent renal disease Cardiovascular No concurrent cardiac disease Pulmonary No concurrent pulmonary disorder Other Not pregnant nursing Fertile patient must use effective contraception Mini mental score least 15 No know hypersensitivity carmustine Gliadel wafers No serious concurrent medical illness infection PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy No prior cranial irradiation Surgery See Disease Characteristics No prior surgery involve brain metastasis primary brain tumor ( ) ( except benign intracranial lesion pituitary adenoma , meningioma , schwannoma ) Other Concurrent systemic therapy allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2003</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>tumor metastatic brain</keyword>
</DOC>